These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 1827660)
1. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries. Satoh K; Yamada H; Taira N Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660 [TBL] [Abstract][Full Text] [Related]
2. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery. Fujiwara T; Angus JA Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500 [TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil. Yanagisawa T; Teshigawara T; Taira N Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290 [TBL] [Abstract][Full Text] [Related]
4. Comparative relaxant effects of cromakalim and pinacidil on the tonic contraction of canine coronary artery induced by phorbol 12,13-dibutylate. Kuromaru O; Sakai K Clin Exp Pharmacol Physiol; 1996; 23(6-7):493-7. PubMed ID: 8800572 [TBL] [Abstract][Full Text] [Related]
5. The group at C2 of N-ethylnicotinamide determines the vasodilator potencies and mechanisms of action of nicorandil and its congeners in canine coronary arteries. Satoh K; Yamada H; Yoneyama F; Taira N Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):589-95. PubMed ID: 1839805 [TBL] [Abstract][Full Text] [Related]
6. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle. Satoh E; Yanagisawa T; Taira N Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209 [TBL] [Abstract][Full Text] [Related]
7. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery. Ksoll E; Parsons AA; Mackert JR; Schilling L; Wahl M Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131 [TBL] [Abstract][Full Text] [Related]
8. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model]. Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882 [TBL] [Abstract][Full Text] [Related]
9. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery. Eltze M Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466 [TBL] [Abstract][Full Text] [Related]
10. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo. Kamijo T; Iwai T; Haruta K; Takeda K Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999 [TBL] [Abstract][Full Text] [Related]
11. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide. Imagawa J; Akima M; Nabata H; Taira N J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676 [TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries. Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002 [TBL] [Abstract][Full Text] [Related]
13. Hyperpolarization induced by K+ channel openers inhibits Ca2+ influx and Ca2+ release in coronary artery. Yanagisawa T; Yamagishi T; Okada Y Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():565-74. PubMed ID: 8251426 [TBL] [Abstract][Full Text] [Related]
14. Vasodilatation of canine cerebral arteries by nicorandil, pinacidil and lemakalim. Zhang H; Stockbridge N; Weir B; Vollrath B; Cook D Gen Pharmacol; 1992 Mar; 23(2):197-201. PubMed ID: 1353469 [TBL] [Abstract][Full Text] [Related]
15. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery. Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782 [TBL] [Abstract][Full Text] [Related]
16. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries. Iwamoto T; Nishimura N; Morita T; Sukamoto T J Pharm Pharmacol; 1993 Apr; 45(4):292-7. PubMed ID: 8098370 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil. Holzmann S; Kukovetz WR; Braida C; Pöch G Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362 [TBL] [Abstract][Full Text] [Related]
18. Nicorandil as a nitrate, and cromakalim as a potassium channel opener, dilate isolated porcine large coronary arteries in an agonist-nonselective manner. Satoh K; Mori T; Yamada H; Taira N Cardiovasc Drugs Ther; 1993 Aug; 7(4):691-9. PubMed ID: 8241013 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: comparison with other NO donors. Matsumoto T; Takahashi M; Omura T; Takaoka A; Liu Q; Nakae I; Kinoshita M J Cardiovasc Pharmacol; 1997 Jun; 29(6):772-9. PubMed ID: 9234658 [TBL] [Abstract][Full Text] [Related]